Product image of Mercilon (Desogestrel, Ethinylestradiol) supplied by GNH India

Mercilon

Active Ingredient:
Desogestrel, Ethinylestradiol
Origin:
EU

Mercilon (Desogestrel, Ethinylestradiol)

Desogestrel/Ethinylestradiol, the active ingredients in Mercilon, are a combined oral contraceptive presented as oral tablets for oral use. It prevents pregnancy in women of reproductive age by inhibiting ovulation and altering cervical mucus.
GNH India supplies Mercilon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Organon Belgium B.V.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Mercilon is a combined hormonal contraceptive that acts on the reproductive endocrine system to prevent pregnancy.

  • Contraception: provides reliable prevention of pregnancy for women of child‑bearing potential.
  • Menstrual cycle regulation: helps establish a more predictable menstrual pattern.
  • Acne management: may improve mild to moderate acne associated with hormonal fluctuations.

How It Works

  • Desogestrel is a progestogenic agent that suppresses the mid‑cycle surge of luteinizing hormone (LH) and follicle‑stimulating hormone (FSH), thereby preventing ovulation. Ethinylestradiol provides estrogenic activity that stabilises the endometrial lining and enhances the inhibition of ovulation, while also thickening cervical mucus to impede sperm penetration.

Side Effects

Mercilon may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

  • Nausea: mild stomach upset, often improves with continued use.
  • Headache: tension‑type or migraine‑like pain.
  • Breast tenderness: temporary swelling or discomfort.
  • Spotting or breakthrough bleeding: irregular bleeding between periods.
  • Weight change: slight fluid retention or appetite variation.
  • Mood changes: mild irritability or emotional fluctuations.

Serious or Rare Side Effects

  • Venous thromboembolism: deep vein thrombosis or pulmonary embolism.
  • Arterial thrombosis: stroke or myocardial infarction.
  • Hypertension: significant increase in blood pressure.
  • Liver dysfunction: jaundice or abnormal liver enzymes.
  • Gallbladder disease: gallstones or cholecystitis.
  • Severe allergic reaction: rash, swelling, or anaphylaxis.

Precautions & Warnings

Before prescribing Mercilon, clinicians should evaluate individual risk factors and contraindications.

  • Smoking: avoid use in women over 35 who smoke due to increased thrombotic risk.
  • Cardiovascular disease: contraindicated in patients with history of stroke, myocardial infarction, or uncontrolled hypertension.
  • Liver disease: use with caution in severe hepatic impairment.
  • Migraine with aura: avoid because of elevated stroke risk.
  • Pregnancy: discontinue immediately if pregnancy is confirmed.
  • Store at ambient temperature: keep below 25 °C, retain original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Mercilon can interact with several medicines that affect its efficacy or safety.

Major Interactions (Avoid)

  • Antiepileptic drugs (e.g., carbamazepine, phenytoin): may reduce contraceptive effectiveness.
  • Rifampicin and other potent enzyme inducers: can markedly lower hormone levels.
  • Certain antivirals (e.g., ritonavir): may increase risk of hormonal side effects.

Moderate Interactions (Monitor Closely)

  • Antifungals (e.g., fluconazole): may increase plasma concentrations of ethinylestradiol.
  • St. John’s wort: may diminish contraceptive efficacy.
  • Diuretics: can affect fluid balance and blood pressure, requiring monitoring.

Frequently Asked Questions

Mercilon is a combined oral contraceptive containing desogestrel and ethinylestradiol. It is prescribed to prevent pregnancy in women of reproductive age by inhibiting ovulation and altering cervical mucus, providing a reliable method of hormonal birth control.

Desogestrel acts as a progestin that suppresses the mid‑cycle surge of luteinizing hormone and follicle‑stimulating hormone, preventing ovulation. Ethinylestradiol supplies estrogenic activity that stabilises the endometrium and further supports ovulation inhibition while thickening cervical mucus to block sperm entry.

The dosing regimen for Mercilon is determined by the prescribing healthcare professional. Typically, it is taken as a daily oral tablet following the specific cycle schedule indicated on the prescription, but exact dosing should always be confirmed with the prescriber.

Mercilon is contraindicated during pregnancy; it should be stopped immediately if pregnancy occurs. While limited data exist for breastfeeding, most guidelines advise caution and recommend discussing alternative contraceptive options with a healthcare provider.

To order Mercilon, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mercilon contains desogestrel, a third‑generation progestin, which is associated with a lower incidence of androgenic side effects such as acne compared with older progestins. Its efficacy in preventing pregnancy is comparable to other combined oral contraceptives, while the side‑effect profile may differ slightly.

Mercilon tablets should be stored at ambient temperature, below 25 °C. Keep them in the original blister pack, protect from moisture and direct sunlight, and store out of reach of children.

Mercilon is taken orally as a tablet once daily, preferably at the same time each day. The typical regimen involves 21 active tablets followed by a 7‑day hormone‑free interval, during which withdrawal bleeding occurs.

Serious risks include venous thromboembolism, arterial thrombosis (stroke or myocardial infarction), severe hypertension, and liver disorders. Patients should be aware of symptoms such as leg pain, sudden shortness of breath, severe headache, visual changes, or jaundice and seek immediate medical attention if they occur.

Mercilon is contraindicated in women who are pregnant, have a history of thromboembolic disorders, uncontrolled hypertension, severe liver disease, known or suspected breast cancer, or who smoke cigarettes and are over 35 years of age. It should also be avoided in individuals with known hypersensitivity to any component of the product.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.